GSK3B and breast carcinoma: Data from our work describe a novel regulator of breast DDCCs survival, EphB6, that modulates adaptation to lung microenvironment through the GSK3β-TFEB-lysosomal axis, providing potential novel liabilities of disseminated dormant breast cancer cells.